Interest payments on the debt consume 15% of the total budget. Meanwhile, the debt has contributed to a $1.8 trillion deficit ...

Both CME Group's FedWatch tool and Kalshi indicate a high likelihood that the Federal Reserve will raise interest rates at ...

From 2025 to 2028, analysts expect Bloom's revenue and adjusted EBITDA to grow at CAGRs of 70% and 120%, respectively, as the ...

Micron Technology ( MU -6.67%) has been one of the hottest stocks to own this year, with its value rising by more than 240% ...

Pelacarsen is an antisense oligonucleotide (ASO) that was designed to inhibit the production of lipoprotein (a), or Lp (a) ...

The initial public offering (IPO) was historic for its size, and Einhorn notes that SpaceX is still making history, citing ...

With such a large percentage of Google Cloud revenue coming from TPUs, Alphabet is seeing a very short payback period for its ...

The two primary electric vertical takeoff and landing (eVTOL) aircraft stocks are Archer Aviation ( ACHR +2.38%) and Joby ...

Oracle's stock is trading at about 23 times its trailing profits, which is right in line with the S&P 500 average. While it ...

Then, on the August earnings call, Musk claimed that SpaceX's annual recurring revenue (ARR) could hit $100 billion by the ...

Sure, Moderna is developing several mRNA-based cancer therapies, but no mRNA-based vaccine has ever been approved for cancer.

Nvidia fell, Microsoft rose, and both moves trace back to the same weekend essay. Meanwhile, oil prices are soaring again.